Potential Side Effects
Some HIFU patients experience frequency, urgency, mild discomfort or discharge in urinary stream. Studies performed outside the US report that potential side effects may also include urinary stricture (18%)2, retention (0.6%)1, incontinence (0.6%)1, erectile dysfunction (20%)1 and rectal fistula (1%)1
1 Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer. Toyoaki Uchida, et al. Dept. of Urology University of Tokai Hachioji Hospital. International Journal of Urology 2006.
2 Toyaki U., Shiro B., Akira I., et al., Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer: A multicenter study.Acta Urol. Jpn. Vol. 51, No. 10, 2005.
IMPORTANT INFORMATION
The Sonablate® 500 is not approved for use in the U.S. The Sonablate® 500 remains investigational in the U.S. and is being studied for the treatment of prostate cancer in clinical trials in the U.S. FDA has made no decision as to the safety or efficacy of the Sonablate® 500 for the treatment of prostate cancer.
The information provided on this website is for general information purposes only and is not intended to replace sound professional medical advice and care. All treatment options and potential outcomes and complications should be discussed with a qualified healthcare provider.
 Next: HIFU Video Animation
|
